Page last updated: 2024-09-04

moxifloxacin and apixaban

moxifloxacin has been researched along with apixaban in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (apixaban)	Trials (apixaban)	Recent Studies (post-2010) (apixaban)
3,157	552	1,690	2,405	255	2,250

Protein Interaction Comparison

Protein	Taxonomy	moxifloxacin (IC50)	apixaban (IC50)
Coagulation factor X	Homo sapiens (human)		0.22

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boyd, R; Byon, W; Frost, C; LaCreta, F; Moore, K; Nepal, S; Reeves, RA	1

Trials

1 trial(s) available for moxifloxacin and apixaban

Article	Year
Randomized, blinded, placebo- and positive-controlled crossover study to determine the effect of multiple doses of apixaban on the QTc interval. Journal of clinical pharmacology, 2015, Volume: 55, Issue:5 Topics: Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Factor Xa Inhibitors; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pyrazoles; Pyridones	2015

Article

Year

Randomized, blinded, placebo- and positive-controlled crossover study to determine the effect of multiple doses of apixaban on the QTc interval.

Journal of clinical pharmacology, 2015, Volume: 55, Issue:5

Topics: Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Factor Xa Inhibitors; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pyrazoles; Pyridones

2015